The pharmaceutical sector in India showed mixed performance on March 6, 2026, during early trading hours. Data from around 9:46 AM to 9:50 AM IST indicated the S&P BSE HEALTHCARE Index at 43,702.0, up 0.1%. Over the prior 30 days, the index gained 3.6%, and over the last year, it rose 13.3%.
The benchmark S&P BSE SENSEX stood at 79,736.6, down 0.3% (or -0.35% in some references).
Within the pharmaceuticals sector, stocks displayed varied movements:
Notable Gainers (based on provided early data)
- Shilpa Medicare: +3.08% (BSE)
- Aster DM Healthcare: +2.56%
- Unichem Lab: +2.13%
- Wockhardt: +2.12%
- Corona Remedies Ltd.: +2.03%
- Supriya Lifescience: +1.91%
- Natco Pharma: +1.84%
- Granules India: +1.79%
- Ajanta Pharma: +1.38%
- Biocon: +1.36%
Other Movements
Many large-cap names traded flat to marginally lower or higher:
- Sun Pharma: -0.05% (BSE) / -0.37% (NSE)
- Cipla: -0.01% (BSE) / -0.17% (NSE)
- Divi’s Laboratories: +0.68% (BSE) / +0.31% (NSE)
- Dr. Reddy’s Lab: -0.53% (BSE) / -0.82% (NSE)
- Lupin: +0.67% (BSE) / +0.69% (NSE)
- Zydus Lifesciences: +0.01% (BSE) / 0.00% (NSE)
Sector Context
The sector update noted top gainers including LINK PHARMA (up 10.3%) and SUNIL HEALTHCARE (up 8.3%), while top losers included KREBS BIOCHEMICALS (down 8.3%) and VINEET LABORATORIES (down 5.6%). These reflect specific movements beyond the main listed stocks.
Note: These figures represent snapshot prices from early morning trading on March 6, 2026 (BSE at 09:46 AM IST, NSE at 09:49:59 AM IST). Stock prices fluctuate throughout the day, influenced by market conditions, news, and broader indices. For real-time or closing values, refer to official BSE/NSE sources.